Sudarshan Pharma Industries Limited specializes in manufacturing specialty chemicals and active pharmaceutical ingredients, focusing primarily on vitamins and APIs. The company operates within the domestic and international markets.

Sudarshan Pharma has a strong presence in pharmaceutical formulation with more than 100 generic products under its brand and collaborates with WHO and FDA-approved plants.

They have established significant connections with storage facilities in Maharashtra and Himachal Pradesh for effective distribution and logistics, benefiting from supportive state policies.

The introduction of a subsidiary, Ratna Lifesciences, expands their capabilities, especially in vitamin production, with successful development of Vitamin B6 and progress in Vitamin B1.

The company conducted an IPO raising Rs. 50 Crore, indicating expansion ambitions and financial strengthening for future projects.